Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir
Filetype[PDF-288.59 KB]


No Related Documents.
You May Also Like:
  1. Human Influenza Surveillance: the Demand to Expand
    Personal Author:
    Layne, Scott P.
    Published Date:
    Apr 2006
    Source:
    Emerg Infect Dis. 12(4):562-568.
    Description:
    The World Health Organization Influenza Program is one of the best developed and longest running infectious disease surveillance systems that exists. It maintains a worldwide watch of influenza's evolution to assist delivery of appropriately formulat...
    File Type:
    Filetype[PDF - 133.86 KB]
  2. I222 Neuraminidase Mutations Further Reduce Oseltamivir Susceptibility of Indonesian Clade 2.1 Highly Pathogenic Avian Influenza A(H5N1) Viruses
    Personal Author:
    McKimm-Breschkin, Jennifer L.; Barrett, Susan; Pudjiatmoko,; Azhar, Muhammad; Wong, Frank Y. K.; Selleck, Paul; Mohr, Peter G.; McGrane, James; Kim, Mia;
    Published Date:
    Jun 11 2013
    Source:
    PLoS One. 2013; 8(6).
    Description:
    We have tested the susceptibility to neuraminidase inhibitors of 155 clade 2.1 H5N1 viruses from Indonesia, isolated between 2006-2008 as well as 12 clade 1 isolates from Thailand and Cambodia from 2004-2007 using a fluorometric MUNANA-based enzyme i...
    File Type:
    Filetype[PDF - 688.08 KB]
  3. Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Bridges, Carolyn B.; Cox, Nancy (Nancy J.); Fukuda, Keiji; Harper, Scott A.; Uyeki, Timothy M.;
    Corporate Authors:
    National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases.. National Immunization Program (Centers for Disease Control and Prevention. Epidemiology and Surveillance Division.. United States. Advisory Committee on Immunization Practices..
    Published Date:
    May 28, 2004
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 53, no. RR-6
    Description:
    This report updates 1999 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 1999;48[No. RR-4]: 1-29). These recommendations include five principal changes: a) the age ...
    Status:
    superseded
    File Type:
    Filetype[PDF - 528.28 KB]
  4. Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein
    Personal Author:
    Triana-Baltzer, Gallen B.; Gubareva, Larisa V.; Klimov, Alexander I.; Wurtman, David F.; Moss, Ronald B.; Hedlund, Maria; Larson, Jeffrey L.; Belshe, Robert B.; Fang, Fang;
    Published Date:
    November 06 2009
    Source:
    PLoS One. 2009; 4(11)
    Description:
    Antiviral drug resistance for influenza therapies remains a concern due to the high prevalence of H1N1 2009 seasonal influenza isolates which display H274Y associated oseltamivir-resistance. Furthermore, the emergence of novel H1N1 raises the potenti...
    File Type:
    Filetype[PDF - 288.85 KB]
  5. Reduced Sensitivity of Influenza A (H5N1) to Oseltamivir
    Personal Author:
    McKimm-Breschkin, Jennifer L.; Selleck, Paul W.; Usman, Tri Bhakti; Johnson, Michael A.;
    Published Date:
    Sep 2007
    Source:
    Emerg Infect Dis. 13(9):1354-1357.
    Description:
    We tested the neuraminidase drug sensitivity of clade 1 and clade 2 influenza A (H5N1). All viruses demonstrated similar sensitivity to zanamivir, but compared with the 2004 clade 1 viruses, the Cambodian 2005 viruses were 6-fold less sensitive and t...
    File Type:
    Filetype[PDF - 263.57 KB]